Advanced Clinical Expands Global Reach with New Office in India
India, Wednesday, 31 July 2024.
Advanced Clinical opens a strategic office in Ahmedabad, India, boosting its global clinical research capabilities. This expansion aims to enhance service delivery across time zones and leverage India’s talent pool for innovative drug development solutions.
Enhancing Clinical Research Landscape
Advanced Clinical’s new office in Ahmedabad, India, marks a significant milestone in the company’s ongoing global expansion efforts. This move underscores the organization’s commitment to addressing the evolving needs of its clients and becoming more competitive in the global market. By leveraging India’s exceptional talent and resources, Advanced Clinical aims to deliver innovative drug development solutions that meet the dynamic demands of the market.
Strategic Benefits of Expansion
The strategic location in Ahmedabad allows Advanced Clinical to provide more efficient services to clients across various time zones and regions. Julie Ross, President and CEO of Advanced Clinical, stated, ‘Based on our continued growth and customer demand, our office in India will offer seamless service enhancement to our customers while strengthening our operations in the Asia Pacific region for the conduct of clinical trials.’ This expansion not only enhances service delivery but also positions the company to better support global clinical trials and innovations in biopharmaceutical development.
Operational Leadership in India
Bharat B. Doshi has been appointed as the General Manager of the new office in India. Mr. Doshi is a seasoned executive with extensive experience in helping Contract Research Organizations (CROs) establish scalable operations in India. His leadership will be crucial in operationalizing teams and expanding Advanced Clinical’s footprint throughout India and Asia. Dr. Andreas Amrein, Senior Vice President and Managing Director, Asia Pacific and Japan, noted, ‘Our expanded presence will provide additional core clinical solutions and leverage the talented professionals in India, aligning with our values.’
India’s Favorable Business Environment
India’s favorable business environment is a key factor in Advanced Clinical’s decision to expand its operations there. The Indian government has eased foreign direct investment (FDI) restrictions, raising foreign equity caps for insurance and defense sectors, thereby improving the business climate. Ranked 63rd in the World Bank’s Doing Business 2020 study, India has made significant strides in creating a more conducive environment for global businesses. Junaid Ahmad, World Bank Country Director in India, remarked, ‘India’s impressive progression in the Doing Business rankings over the past few years is a tremendous achievement, especially for an economy that is as large and complex as India’s.’
Conclusion and Future Prospects
Advanced Clinical’s new office in Ahmedabad is a strategic move that will significantly enhance its global clinical research capabilities. By tapping into India’s vast talent pool and favorable business conditions, the company is poised to deliver innovative drug development solutions that cater to the evolving demands of the global market. This expansion not only strengthens Advanced Clinical’s presence in the Asia Pacific region but also underscores its commitment to providing a better clinical experience across the drug development journey.